{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/33366"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/33366","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"Bacteriophage-Functionalized Expanded Polytetrafluoroethylene Vascular Grafts for Biofilm Control","abstract":"Cardiovascular device infections remain difficult to manage because bacteria rapidly adhere to biomaterial surfaces and mature into biofilms that resist antimicrobial therapy. This thesis investigates bacteriophage-based strategies for cardiovascular device infection control, with emphasis on bacteriophage-functionalized expanded polytetrafluoroethylene (ePTFE) vascular grafts. Chapter 1 introduces the clinical problem, rationale, research objective, and thesis organization. Chapter 2 reviews the biological basis of bacteriophage therapy, biofilm disruption, phage-antibiotic interactions, resistance, immune considerations, cardiovascular device applications, and regulatory issues for phage-functionalized devices. Chapter 3 describes the materials and methods used for ePTFE surface functionalization, phage preparation, surface characterization, biofilm assays, crystal violet staining, XTT metabolic activity testing, microscopy, microfluidic washing, bovine serum exposure, and plasma-contacting assays. Chapter 4 presents the experimental results. Surface characterization showed route-dependent ePTFE modification, while biological testing showed that durable retention of infectious phage was the main determinant of antimicrobial performance. GPTMS phage grafts produced the strongest retention-linked biofilm suppression, retained infectious phage after sustained microfluidic washing, preserved visible antibacterial activity after bovine serum exposure, and did not increase peak thrombin relative to untreated ePTFE in initial plasma-contacting screening. Chapter 5 integrates these findings and identifies the main translational needs, including broader pathogen testing, phage cocktail development, human blood-contacting validation, endothelialization assessment, dry-storage testing, sterilization compatibility, and larger vascular-flow models. Together, these findings support GPTMS-mediated bacteriophage immobilization as a proof-of-concept antimicrobial coating strategy for ePTFE vascular grafts while defining the next studies required before clinical translation.","abstract_html":"Cardiovascular device infections remain difficult to manage because bacteria rapidly adhere to biomaterial surfaces and mature into biofilms that resist antimicrobial therapy. This thesis investigates bacteriophage-based strategies for cardiovascular device infection control, with emphasis on bacteriophage-functionalized expanded polytetrafluoroethylene (ePTFE) vascular grafts. Chapter 1 introduces the clinical problem, rationale, research objective, and thesis organization. Chapter 2 reviews the biological basis of bacteriophage therapy, biofilm disruption, phage-antibiotic interactions, resistance, immune considerations, cardiovascular device applications, and regulatory issues for phage-functionalized devices. Chapter 3 describes the materials and methods used for ePTFE surface functionalization, phage preparation, surface characterization, biofilm assays, crystal violet staining, XTT metabolic activity testing, microscopy, microfluidic washing, bovine serum exposure, and plasma-contacting assays. Chapter 4 presents the experimental results. Surface characterization showed route-dependent ePTFE modification, while biological testing showed that durable retention of infectious phage was the main determinant of antimicrobial performance. GPTMS phage grafts produced the strongest retention-linked biofilm suppression, retained infectious phage after sustained microfluidic washing, preserved visible antibacterial activity after bovine serum exposure, and did not increase peak thrombin relative to untreated ePTFE in initial plasma-contacting screening. Chapter 5 integrates these findings and identifies the main translational needs, including broader pathogen testing, phage cocktail development, human blood-contacting validation, endothelialization assessment, dry-storage testing, sterilization compatibility, and larger vascular-flow models. Together, these findings support GPTMS-mediated bacteriophage immobilization as a proof-of-concept antimicrobial coating strategy for ePTFE vascular grafts while defining the next studies required before clinical translation.","abstract_has_math":false,"creators":["Alfadhli, Abeer"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Biomedical Engineering","school":null,"contributors":[],"advisors":["Didar, Tohid"],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T19:30:43Z","subjects":["Bacteriophage","vascular graft","ePTFE","MEDICINE::Dermatology and venerology,clinical genetics, internal medicine::Internal medicine::Cardiovascular medicine","expanded polytetrafluoroethylene"],"languages":["en_US"],"rights":["Attribution-NonCommercial-NoDerivs 2.5 Canada"],"rights_urls":["http://creativecommons.org/licenses/by-nc-nd/2.5/ca/"],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/405"],"render_values":[{"text":"https://doi.org/10.71548/405","href":"https://doi.org/10.71548/405","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/11375/33366","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/11375/33366","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F33366","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Didar, Tohid"]},{"key":"dc:contributor.department","label":"Department","values":["Biomedical Engineering"]},{"key":"dc:creator","label":"Author","values":["Alfadhli, Abeer"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-07-17T19:14:29Z"]},{"key":"dc:date.issued","label":"Date","values":["2026"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Bacteriophage","vascular graft","ePTFE","MEDICINE::Dermatology and venerology,clinical genetics, internal medicine::Internal medicine::Cardiovascular medicine","expanded polytetrafluoroethylene"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]},{"key":"dc:rights","label":"Dc Rights","values":["Attribution-NonCommercial-NoDerivs 2.5 Canada"]},{"key":"dc:rights.uri","label":"Rights URI","values":["http://creativecommons.org/licenses/by-nc-nd/2.5/ca/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/11375/33366","https://doi.org/10.71548/405"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Cardiovascular device infections remain difficult to manage because bacteria rapidly adhere to biomaterial surfaces and mature into biofilms that resist antimicrobial therapy. This thesis investigates bacteriophage-based strategies for cardiovascular device infection control, with emphasis on bacteriophage-functionalized expanded polytetrafluoroethylene (ePTFE) vascular grafts. Chapter 1 introduces the clinical problem, rationale, research objective, and thesis organization. Chapter 2 reviews the biological basis of bacteriophage therapy, biofilm disruption, phage-antibiotic interactions, resistance, immune considerations, cardiovascular device applications, and regulatory issues for phage-functionalized devices. Chapter 3 describes the materials and methods used for ePTFE surface functionalization, phage preparation, surface characterization, biofilm assays, crystal violet staining, XTT metabolic activity testing, microscopy, microfluidic washing, bovine serum exposure, and plasma-contacting assays. Chapter 4 presents the experimental results. Surface characterization showed route-dependent ePTFE modification, while biological testing showed that durable retention of infectious phage was the main determinant of antimicrobial performance. GPTMS phage grafts produced the strongest retention-linked biofilm suppression, retained infectious phage after sustained microfluidic washing, preserved visible antibacterial activity after bovine serum exposure, and did not increase peak thrombin relative to untreated ePTFE in initial plasma-contacting screening. Chapter 5 integrates these findings and identifies the main translational needs, including broader pathogen testing, phage cocktail development, human blood-contacting validation, endothelialization assessment, dry-storage testing, sterilization compatibility, and larger vascular-flow models. Together, these findings support GPTMS-mediated bacteriophage immobilization as a proof-of-concept antimicrobial coating strategy for ePTFE vascular grafts while defining the next studies required before clinical translation."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Master of Applied Science (MASc)"]},{"key":"dc:title","label":"Title","values":["Bacteriophage-Functionalized Expanded Polytetrafluoroethylene Vascular Grafts for Biofilm Control"]},{"key":"dc:title.alternative","label":"Alternative Title","values":["Bacteriophage Therapy in Cardiovascular Medicine: A Paradigm Shift in the Prevention of Device-Related Infections","GPTMS-Mediated Bacteriophage Functionalization of ePTFE Vascular Grafts Improves Durable Phage Retention and Suppresses Staphylococcus aureus Biofilm Formation"]},{"key":"others:access_status","label":"Others Access Status","values":["embargo"]}]}],"canonical_facts":{"dc:contributor.advisor":["Didar, Tohid"],"dc:contributor.department":["Biomedical Engineering"],"dc:creator":["Alfadhli, Abeer"],"dc:date.accessioned":["2026-07-17T19:14:29Z"],"dc:date.issued":["2026"],"dc:description.abstract":["Cardiovascular device infections remain difficult to manage because bacteria rapidly adhere to biomaterial surfaces and mature into biofilms that resist antimicrobial therapy. This thesis investigates bacteriophage-based strategies for cardiovascular device infection control, with emphasis on bacteriophage-functionalized expanded polytetrafluoroethylene (ePTFE) vascular grafts. Chapter 1 introduces the clinical problem, rationale, research objective, and thesis organization. Chapter 2 reviews the biological basis of bacteriophage therapy, biofilm disruption, phage-antibiotic interactions, resistance, immune considerations, cardiovascular device applications, and regulatory issues for phage-functionalized devices. Chapter 3 describes the materials and methods used for ePTFE surface functionalization, phage preparation, surface characterization, biofilm assays, crystal violet staining, XTT metabolic activity testing, microscopy, microfluidic washing, bovine serum exposure, and plasma-contacting assays. Chapter 4 presents the experimental results. Surface characterization showed route-dependent ePTFE modification, while biological testing showed that durable retention of infectious phage was the main determinant of antimicrobial performance. GPTMS phage grafts produced the strongest retention-linked biofilm suppression, retained infectious phage after sustained microfluidic washing, preserved visible antibacterial activity after bovine serum exposure, and did not increase peak thrombin relative to untreated ePTFE in initial plasma-contacting screening. Chapter 5 integrates these findings and identifies the main translational needs, including broader pathogen testing, phage cocktail development, human blood-contacting validation, endothelialization assessment, dry-storage testing, sterilization compatibility, and larger vascular-flow models. Together, these findings support GPTMS-mediated bacteriophage immobilization as a proof-of-concept antimicrobial coating strategy for ePTFE vascular grafts while defining the next studies required before clinical translation."],"dc:description.degree":["Master of Applied Science (MASc)"],"dc:identifier.uri":["https://hdl.handle.net/11375/33366","https://doi.org/10.71548/405"],"dc:language.iso":["en_US"],"dc:rights":["Attribution-NonCommercial-NoDerivs 2.5 Canada"],"dc:rights.uri":["http://creativecommons.org/licenses/by-nc-nd/2.5/ca/"],"dc:subject":["Bacteriophage","vascular graft","ePTFE","MEDICINE::Dermatology and venerology,clinical genetics, internal medicine::Internal medicine::Cardiovascular medicine","expanded polytetrafluoroethylene"],"dc:title":["Bacteriophage-Functionalized Expanded Polytetrafluoroethylene Vascular Grafts for Biofilm Control"],"dc:title.alternative":["Bacteriophage Therapy in Cardiovascular Medicine: A Paradigm Shift in the Prevention of Device-Related Infections","GPTMS-Mediated Bacteriophage Functionalization of ePTFE Vascular Grafts Improves Durable Phage Retention and Suppresses Staphylococcus aureus Biofilm Formation"],"dc:type":["Thesis"],"others:access_status":["embargo"]},"updated_at":"2026-11-18T19:30:43Z"}